Literature DB >> 15066933

Colorectal cancer screening adherence in a general population.

Mark W Yeazel1, Timothy R Church, Resa M Jones, Laura K Kochevar, Gavin D Watt, Jill E Cordes, Deborah Engelhard, Steven J Mongin.   

Abstract

BACKGROUND: This article describes the self-reported colorectal cancer (CRC) screening adherence rates of adults, aged 50 years and older, living in five nonurban Minnesota counties.
METHODS: During the year 2000, 1693 eligible respondents, aged 50 years and older, from a randomly selected sample completed a survey assessing CRC screening adherence (approximately 86.3% response). The survey allowed differentiation between the four CRC screening modalities but did not differentiate between screening and diagnostic testing. Adjustment for nonresponse was performed using a version of Horvitz-Thompson weighting accounting for unknown eligibility.
RESULTS: 24.5% of respondents had a fecal occult blood test within 1 year of the survey, 33.8% had flexible sigmoidoscopy within 5 years, 29.3% had a colonoscopy within 10 years, and 13.7% had a barium enema within the last 5 years. Overall, 55.3% of respondents reported testing by any modality; thus, 44.7% were not adherent to screening guidelines.
CONCLUSIONS: This study improves on previous attempts to characterize CRC screening adherence by assessing all four modalities of screening as recommended by current screening guidelines, by focusing on nonadherence, and by rigorously accounting for nonresponse. This study confirms that nearly half of the population remains unscreened by any method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066933

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  12 in total

1.  Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.

Authors:  Haiyun Yang; Zhizheng Ge; Jun Dai; Xiaobo Li; Yunjie Gao
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

2.  Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies.

Authors:  Federica Domati; Estratios Travlos; Claudia Cirilli; Giuseppina Rossi; Piero Benatti; Massimiliano Marino; Giovanni Ponti; Maria Vandelli; Simone Valmori; Amal Oursana; Annalisa Pezzi; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2008-09-20       Impact factor: 3.397

3.  Predictors of nonadherence to screening colonoscopy.

Authors:  Thomas D Denberg; Trisha V Melhado; John M Coombes; Brenda L Beaty; Kenneth Berman; Tim E Byers; Alfred C Marcus; John F Steiner; Dennis J Ahnen
Journal:  J Gen Intern Med       Date:  2005-11       Impact factor: 5.128

4.  Colorectal cancer screening among obese versus non-obese patients in primary care practices.

Authors:  Jeanne M Ferrante; Pamela Ohman-Strickland; Shawna V Hudson; Karissa A Hahn; John G Scott; Benjamin F Crabtree
Journal:  Cancer Detect Prev       Date:  2006-10-25

5.  Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment?

Authors:  Sara N Red; Elisabeth C Kassan; Randi M Williams; Sofiya Penek; John Lynch; Chiledum Ahaghotu; Kathryn L Taylor
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

6.  Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice.

Authors:  Emina H Huang; Laura A Johnson; Kathryn Eaton; Mark J Hynes; Joseph E Carpentino; Peter D R Higgins
Journal:  Dig Dis Sci       Date:  2010-02-26       Impact factor: 3.199

7.  Patient Beliefs About Colon Cancer Screening.

Authors:  John W Ely; Barcey T Levy; Jeanette Daly; Yinghui Xu
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

8.  Colon polyp model use for educating about colorectal cancer screening in the Iowa Research Network.

Authors:  Jeanette M Daly; Yinghui Xu; Barcey T Levy
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

9.  History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy.

Authors:  Luigina Bonelli; Stefania Sciallero; Carlo Senore; Marco Zappa; Hugo Aste; Bruno Andreoni; Donato Angioli; Roberto Ferraris; Stefano Gasperoni; Giuseppe Malfitana; Marco Pennazio; Wendy Atkin; Nereo Segnan
Journal:  Int J Colorectal Dis       Date:  2005-04-28       Impact factor: 2.571

Review 10.  Methods and novel technology for microRNA quantification in colorectal cancer screening.

Authors:  Laura Moody; Hongshan He; Yuan-Xiang Pan; Hong Chen
Journal:  Clin Epigenetics       Date:  2017-10-24       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.